Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
330
160 µg/kg daily (QD)
480 µg/kg daily (QD)
Placebo
Recovery of GI Function
Time frame: up to 7 days of dosing or until hospital discharge
Ancillary GI Functions
Time frame: up to 7 days of dosing or hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Glendale Memorial Hospital
Glendale, California, United States
Long Beach Memorial Medical Center
Long Beach, California, United States
Univ. of Southern California
Los Angeles, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Palo Alto VA Health Care Ctr
Palo Alto, California, United States
Citrus Memorial Hospital
Inverness, Florida, United States
Pensacola Research Consultants
Pensacola, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
ARS Clinical Trials
Powder Springs, Georgia, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
...and 40 more locations